Skip to content

Drug interactions

Brexucabtagene autoleucel + Dexamethasone

Severity: Major

Brexucabtagene autoleucel and Dexamethasone: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Systemic corticosteroids given before or around CAR-T infusion may blunt T-cell expansion and activity, potentially reducing efficacy, and add to infection risk. Corticosteroids are however standard treatment for cytokine release syndrome and neurotoxicity.

What this interaction means in plain words

Brexucabtagene autoleucel and Dexamethasone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Brexucabtagene autoleucel belongs to Oncology; Dexamethasone belongs to Endocrine.

Evidence level: Moderate

Why it happens

Corticosteroid-mediated lymphocytolytic and immunosuppressive effects can impair CAR-T cell proliferation and function.

What to do

Avoid prophylactic or premedication use of dexamethasone around infusion unless essential. Use it as indicated to treat cytokine release syndrome or neurologic toxicity and monitor for infection.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Brexucabtagene autoleucel and Dexamethasone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Brexucabtagene autoleucel with Dexamethasone?

MediHelp rates the interaction as major. Brexucabtagene autoleucel and Dexamethasone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Systemic corticosteroids given before or around CAR-T infusion may blunt T-cell expansion and activity, potentially reducing efficacy, and add to infection risk. Corticosteroids are however standard treatment for cytokine release syndrome and neurotoxicity.

How serious is the interaction between Brexucabtagene autoleucel and Dexamethasone?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid prophylactic or premedication use of dexamethasone around infusion unless essential. Use it as indicated to treat cytokine release syndrome or neurologic toxicity and monitor for infection.

What other medicines interact with Dexamethasone?

MediHelp also lists interactions of Dexamethasone with, for example, Bcg vaccine live, Mifepristone, Rilpivirine. The full list is on the Dexamethasone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in